8 Coupons
-
Special Offer
-
30% off
.
.eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.
the report was compiled by outside researchers who went into the fda�s own database of �serious adverse [medical-drug] events.� .